Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

ClinicalTrials.gov ID: NCT05465174

Public ClinicalTrials.gov record NCT05465174. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 29, 2026, 8:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Tovorafenib for the Treatment of Newly Diagnosed or Recurrent Craniopharyngioma in Children and Young Adults

Study identification

NCT ID: NCT05465174
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Sabine Mueller, MD, PhD; Other
Enrollment: 57 participants

Conditions and interventions

Conditions

Interventions

Tovorafenib Drug

Drug

Eligibility (public fields only)

Age range: 1 Year to 39 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 11, 2022
Primary completion: Feb 28, 2027
Completion: Feb 29, 2028
Last update posted: Apr 22, 2026

2022 – 2028

United States locations

U.S. sites: 15
U.S. states: 14
U.S. cities: 15

Facility	City	State	ZIP	Site status
University of Alabama at Birmingham	Birmingham	Alabama	35294	Recruiting
Rady Children's Hospital/University of California, San Diego	San Diego	California	92037	Recruiting
University of California, San Francisco	San Francisco	California	94143	Recruiting
University of Florida	Gainesville	Florida	32611	Recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago	Chicago	Illinois	60611	Recruiting
Riley Hospital for Children at Indiana University Health	Indianapolis	Indiana	46202	Recruiting
John Hopkins University	Baltimore	Maryland	21218	Recruiting
Dana-Farber/Boston Children's Harvard Medical School	Boston	Massachusetts	02215	Recruiting
University of Michigan	Ann Arbor	Michigan	48109	Recruiting
Children's Minnesota	Minneapolis	Minnesota	55404	Recruiting
St. Louis Children's Hospital Washington University	St Louis	Missouri	63110	Recruiting
NYU Langone Health	New York	New York	10016	Recruiting
Duke University Medical Center	Durham	North Carolina	27710	Recruiting
Children's Hospital of Philadelphia	Philadelphia	Pennsylvania	19103	Recruiting
University of Utah	Salt Lake City	Utah	84112	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05465174, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 22, 2026 · Synced Apr 29, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05465174 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →